tiprankstipranks
Trending News
More News >
Noxopharm Ltd. (AU:NOX)
:NOX
Australian Market

Noxopharm Ltd. (NOX) Price & Analysis

Compare
2 Followers

NOX Stock Chart & Stats


Financials

NOX FAQ

What was Noxopharm Ltd.’s price range in the past 12 months?
Noxopharm Ltd. lowest share price was AU$0.05 and its highest was AU$0.15 in the past 12 months.
    What is Noxopharm Ltd.’s market cap?
    Noxopharm Ltd.’s market cap is AU$15.20M.
      When is Noxopharm Ltd.’s upcoming earnings report date?
      Noxopharm Ltd.’s upcoming earnings report date is Aug 21, 2025 which is in 47 days.
        How were Noxopharm Ltd.’s earnings last quarter?
        Noxopharm Ltd. released its earnings results on Feb 25, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
          Is Noxopharm Ltd. overvalued?
          According to Wall Street analysts Noxopharm Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Noxopharm Ltd. pay dividends?
            Noxopharm Ltd. does not currently pay dividends.
            What is Noxopharm Ltd.’s EPS estimate?
            Noxopharm Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Noxopharm Ltd. have?
            Noxopharm Ltd. has 292,237,950 shares outstanding.
              What happened to Noxopharm Ltd.’s price movement after its last earnings report?
              Noxopharm Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 12.5%.
                Which hedge fund is a major shareholder of Noxopharm Ltd.?
                Currently, no hedge funds are holding shares in AU:NOX

                Noxopharm Ltd. Stock Smart Score

                Company Description

                Noxopharm Ltd.

                Noxopharm Ltd. (NOX) is an Australian-based biotechnology company that focuses on the development of innovative oncology drug candidates. The company's core products are centered around its proprietary drug technology designed to enhance the effectiveness of existing cancer treatments, particularly in enhancing the body's response to radiotherapy and chemotherapy. Noxopharm operates within the pharmaceutical and biotechnology sectors, aiming to address unmet medical needs in cancer treatment through its novel drug formulations.
                Similar Stocks
                Company
                Price & Change
                Follow
                Opthea
                Biotron
                PYC Therapeutics Limited
                Race Oncology Ltd.
                Proteomics International Laboratories Ltd.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis